When considering dental management for a patient with congestive heart failure (CHF), which is NOT applicable?

In the context of dental management for a patient with congestive heart failure (CHF), it is crucial to consider the impact of medications and overall health on treatment choices. The use of nonsteroidal anti-inflammatory drugs (NSAIDs) long term is not applicable because these medications can lead to fluid retention and may worsen heart failure symptoms. NSAIDs inhibit the synthesis of prostaglandins, which play a role in renal physiology, leading to potential adverse effects in CHF patients, such as worsening renal function and exacerbation of heart failure.

In contrast, the other options address essential considerations for managing a patient with CHF. Patients with CHF are often prescribed medications like loop diuretics, ACE inhibitors, or beta blockers, making choice A relevant for management strategies. Moreover, digitalis is used to improve cardiac function; thus, caution with epinephrine during dental procedures is highlighted in choice B, as it can potentially increase the risk of arrhythmias. Lastly, nitrous oxide/oxygen sedation is considered safe for patients with CHF, as it does not adversely affect cardiac function when used appropriately. Therefore, the contraindication of long-term NSAID use distinguishes this choice as the correct answer for what is not applicable in this scenario.